T he recent publication of the sequence of the human genome will accelerate the discovery of new genetic susceptibility factors for human disease, leading to the development of novel diagnostics and therapeutics. The exhaustive analysis of the human genome sequence will be the focus of the biomedical research community for many years to come. In particular, comparative analysis of the available eukaryotic genome sequences is an important approach to further our understanding of gene structure, function, and evolution. Our initial analysis of the human genome sequence has revealed many interesting features that are relevant to nervous system function, evolution, and disease. We analyzed the prominent features of predicted human proteins involved in neuronal function and prepared a comparative analysis of 146 human genes that have alleles (or mutations) conferring susceptibility for 168 neurologic diseases.
Arch Neurol. 2001; 58:1772 -1778 The recent publication of the sequence of the human genome 1,2 allows a comparative analysis of genes expressed in the nervous system and genes associated with neurologic disease. The nervous system in vertebrates exhibits a high degree of functional complexity, which is supported by a comparatively large number of genes expressed in the nervous tissue. Many human neurologic diseases resulting from genetic mutations have been described. The human genes that confer susceptibility to neurologic diseases belong to many different families and have a large diversity of functions. Human genes that confer disease risk are, of course, not "disease genes," as they are sometimes referred to, because their primary function is certainly not to cause disease. However, the observation that an alteration in a gene sequence results in a detectable disease suggests that the gene product plays a critical role for the survival of the whole organism. We call such gene sequence alterations disease-predisposing alleles.
The comparative analysis of the human genome with the fruit fly and nematode genomes 3, 4 is an important approach to further our understanding of gene function and evolution. Any such analysis must take into account that the human genome is estimated to contain 26 000 to 38 000 genes, the fruit fly genome contains about 14000 genes, and the nematode has about 19000 genes. The expansion of gene families in the human genome is not uniform, but instead reflects the important roles of developmental and cellular processes that are unique to vertebrates.
COMPARATIVE GENOME ANALYSIS
An initial comparative analysis of the human genome with the fruit fly and nematode genomes showed a marked expansion in the number of genes coding for proteins involved in neural development, function, and structure. 1 This finding correlates with, but does not completely explain, the observation that the human nervous system has a much larger number of different neuronal cell types than the fruit fly and nematode nervous systems. 5 Such diversity in neuronal morphology reflects the variety and complexity of gene expression and regulation in the different neuronal cell types of the vertebrate nervous system. Protein families involved in nervous system function and development that are prominently expanded in humans include myelin-related proteins, proteins involved in neuronal signaling (voltagegated ion channels and connexins), and proteins involved in pathway finding by axons and neuronal network formation (cadherins, ephrins, semaphorins, neuropilins, and plexins) (Figure 1) . 1, 6, 7 Of equal interest is the expansion of proteins involved in apoptotic regulation 8 ; the process of programmed cell death or apoptosis is likely to play an important role in neurodegenerative diseases. 9 Also expanded in humans are neuronal cytoskeleton protein families such as actins and microtubuleassociated proteins (MAPs) of the MAP2/tau family ( Figure 1 ). Several of the proteins involved in neuronal communication are multidomain proteins (a protein domain is described as a region on a protein that shows structural, functional, and evolutionary conservation). The observation of "domain shuffling" (whereby new multidomain protein architectures are built by shuffling or adding different evolutionarily conserved protein domains) is a prominent finding in the multidomain proteins involved in neuronal function and structure.
1,2 Therefore, in addition to an increase in the protein repertoire, a substantial increase in the number of protein interactions mediated by those domains is predicted in the human, as compared with the fruit fly and nematode. Selected examples of such novel vertebrate multidomain protein architectures are provided in Figure 2 .
A very important evolutionary difference between vertebrate and invertebrate nervous systems is the appearance of myelinating glial cells, which provide axonal insulation and increase the speed of propagation of action potentials. The human genome has at least 10 genes involved in myelin production; only 1 gene related to myelin proteolipids was detected in the fruit fly and none was detected in the nematode. Mutations in genes involved in myelin production can result in severe demyelinating disorders such as Charcot-Marie-Tooth neuropathy types 1A and 1B and DejerineSottas syndrome (Figure 3 ).
Other protein families involved in neural development, function, and structure, and absent in the fruit fly and nematode, mediate cell adhesion such as the connexin gap junction proteins. These are subunits of the intercellular channels that form electrical synapses in vertebrates. Mutations in the human connexin genes are involved in diseases like X-linked Charcot-MarieTooth neuropathy and autosomal dominant deafness type 3. Several ion channel families show marked expansions in the human genome, for example, the voltage-gated channels ( Figure 1 ). Voltage-gated sodium and potassium channels play a key role in the generation of neuronal action potentials. Mutations in the voltage-gated potassium channel genes are involved in episodic ataxia/myokymia syndrome, autosomal dominant deafness type 2, and benign neonatal epilepsy types 1 and 2. Voltage-gated calcium channels also play a central role in neurotransmitter release; mutations in some members of this gene family are responsible for disorders like episodic ataxia type 2, familial hemiplegic migraine, X-linked congenital .
Protein Domain Architecture Biological or Clinical Relevance
Channel-associated protein of synapse 110 (Chapsyn-110): The human genome shows an expansion of the family of synaptic MAGUK (membrane-associated guanylate kinase) proteins. These proteins interact with and regulate neuronal specific ion channels (NMDA receptors and potassium ion channels).
SHANK is a new family of scaffold proteins. Binding partners include GKAP (a postsynaptic-density protein) as well as several neuronal G-protein-coupled receptors. We performed a comparative analysis of 168 neurogenetic diseases selected from Online Mendelian Inheritance in Man. These diseases result from specific alleles of 146 different human genes ( Figure  3) . The sequence homology analysis was done by means of BlastP as described previously, 12 and no subjective judgments were done for orthologous genes, since these are often quite difficult to determine for Caenorhabditis elegans genes. 12 For the 146 human genes surveyed, we found similar levels of sequence conservation in the fruit fly and nematode. About 56% of those genes show high or intermediate sequence conservation in Drosophila (83 genes) and C elegans (81 genes). This is surprising given the fact that the nervous system in the fruit fly is significantly more complex than that in the nematode. There are 3 cases of gene conservation with the nematode but not the fruit fly: hypoxanthine phosphoribosyltransferase 1 (involved in LeschNyhan syndrome), the MachadoJoseph disease gene, and phytanoylcoenzyme A hydroxylase (Refsum disease). Four genes are conserved in the fruit fly but not in the nematode: otoferlin (autosomal recessive deafness type 9), fragile X mental retardation 1, spinocerebellar ataxia 2, and the sonic hedgehog homologue (holoprosencephaly type 3), a gene that was originally characterized in the fruit fly.
Several human genes in our survey had counterparts in the Drosophila and C elegans genomes. Many of these have been well characterized by molecular studies, particularly with the fruit fly used as the animal model. Examples of such genes are diaphanous homologue (autosomal dominant nonsyndromic deafness type 1); notch homologue 3 (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy [CADASIL]); presenilin 1, presenilin 2, and amyloid ␤-precursor protein (familial early-onset Alzheimer disease); and superoxide dismutase 1 (amyotrophic lateral sclerosis). Genetic studies in the fruit fly have made important contributions to our understanding of their cellular function and the molecular mechanisms involved in neurodegeneration (reviewed by Fortini and Bonini 13 ). Deletion of the fruit fly ␤-amyloid precursor protein-like gene leads to behavioral defects that can be partially rescued by transgenic expression of the human amyloid precursor protein gene.
14 Loss-of-function mutations in the fruit fly presenilin gene cause neurogenic and other developmental defects. 15 In the nematode, deletion of the presenilin homologue sel-12 causes an egglaying defective phenotype that can be fully rescued by normal human presenilin but, interestingly, not by human presenilins carrying mutations linked to familial early-onset Alzheimer disease. 16 The fruit fly has been a very useful animal model for the study of the pathogenesis of polyglutamine repeat diseases such as Huntington and Machado-Joseph diseases. Expression of polyglutamineexpanded huntingtin and MachadoJoseph disease protein in the fruit fly induced neuronal degeneration. 17, 18 An important advantage of the fruit fly and nematode animal model systems is the application of large-scale genetic screening methods to identify novel genes that can modulate the molecular mechanisms of disease. A recent genetic screen identified 2 Drosophila genes that appear to modulate the polyglutamine-induced neurodegeneration, which may lead to better understanding of pathogenesis and ultimately to novel therapeutic development. 19 Other examples of human genes involved in neurologic diseases that have homologues in the fruit fly and nematode are cyclic nucleotidegated channel ␣-3 (achromatopsia), ␣-thalassemia/mental retardation syndrome gene, adenosine triphosphatebinding cassette D1 (adrenoleukodystrophy), platelet-activating factor acetylhydrolase 1b ␣-subunit (lissencephaly type 1), Niemann-Pick disease C1 gene, phenylalanine hydroxylase (phenylketonuria), cyclic nucleotide-gated channel ␣-1 (retinitis pigmentosa), tyrosine hydroxylase (Segawa syndrome), and aldehyde dehydrogenase 3A2 (Sjö grenLarsson syndrome).
About 44% of the human genes in our selected set appear to have no counterparts in the fruit fly and nematode, including the genes involved in myelin production, gap junctions, and voltage-gated ion channels discussed above. Other examples of those nonconserved genes are neuronal ceroid-lipofuscinosis 2, 5, and 8; dentatorubropallidoluysian atrophy; fragile X mental retardation 2; monoamine oxidase A (Brunner syndrome); Norrie disease gene; prion protein gene (Creutzfeldt-Jakob disease, Gerstmann-Strausler-Scheinker syndrome, and fatal familial insomnia); spinocerebellar ataxia 7 and 10; and ␣-synuclein (familial Parkinson disease). Although the gene encoding ␣-synuclein is absent in the fruit fly, expression of human ␣-synuclein in Drosophila has been shown to produce loss of dopaminergic neurons, filamentous intraneuronal inclusions, and locomotor dysfunction reminiscent of Parkinson disease. 20 This suggests that fruit flies have some conservation in the mechanisms leading to neurodegeneration in Parkinson disease, even though one of its components (␣-synuclein) may be absent.
INTERCHROMOSOMAL BLOCK DUPLICATIONS
More than 1000 interchromosomal segmental duplications have been detected in the human genome. 1 Many of these large block duplications appear to have an ancient origin and are likely to predate most vertebrate divergences, having undergone many subsequent deletions and rearrangements. 1 The block duplications range in size from a few genes to segments covering most of a chromosome. Interestingly, many genes that have disease-associated alleles are present in the duplicated segments. Furthermore, in some instances the genes in both duplicated segments have alleles associated with similar diseases. We present examples of inter-(REPRINTED) ARCH NEUROL / VOL 58, NOV 2001chromosomal duplicated segments associated with neurologic diseases (Table) . The homeobox genes sine oculis homologues 3, 1, and 6 are located in duplicated segments in human chromosomes 2 and 14. The Drosophila sine oculis gene is a transcription factor that plays a crucial role in morphogenesis, and its mutant alleles lead to defects in eye morphologic features and neuronal development. Mutations in the human sine oculis homeobox homologue 3 gene are associated with neurodevelopmental alterations in holoprosencephaly type 2. The G protein ␣-transducing activity polypeptide 1 gene in human chromosome 3 encodes a transducin ␣-subunit involved in the stimulation of cyclic guanosine monophosphatephosphodiesterase in rod photoreceptors, and its mutations are associated with congenital stationary night blindness. A duplicated segment containing the G protein ␣-inhibiting subunit 1 gene is present in chromosome 7 (Table) .
The ␣-synuclein gene, associated with familial Parkinson disease, is located in a chromosome 4 segment that is duplicated in chromosome 10, where the ␥-synuclein gene is located. The chromosome 15 gene hexosaminidase A is associated with Tay-Sachs disease, an autosomal recessive progressive neurodegenerative disorder that is prevalent in the Ashkenazi Jewish population. A duplicated segment in chromosome 5 contains the hexosaminidase B ␤ gene, which is associated with Sandhoff disease, a disorder clinically similar to Tay-Sachs disease, but observed mostly in non-Jewish patients. Another example of 2 paralog genes associated with neurogenetic disease is phenylalanine hydroxylase and tyrosine hydroxylase, which are, respectively, part of a segment duplicated in chromosomes 12 and 11. Phenylalanine hydroxylase mutations are associated with phenylketonuria, and tyrosine hydroxylase mutations are linked to autosomal recessive Segawa syndrome, a disease with levodopa-responsive parkinsonism that appears early in infancy (Table) . The gene coding for voltage-gated potassium ion channel 1, linked to episodic ataxia syndrome, is located in a chromosome 12 segment that has duplications in chromosome 1 containing 2 paralog genes of the Shaker-related subfamily of voltage-gated potassium ion channels (Table) . The cochlin precursor gene in chromosome 14 linked to autosomal dominant deafness type 9 is duplicated in chromosome 2. The gene coding for microtubuleassociated protein tau in chromo- (Table) .
CONCLUSIONS
The availability of an assembled human genome sequence will significantly accelerate the discovery of genetic susceptibility factors for human disease. Millions of human single nucleotide polymorphisms and other forms of DNA sequence variations have been added to the single nucleotide polymorphism databases; these markers will enhance the genetic approaches for the identification of disease susceptibility factors. Comparative analyses of genomes from different species and phyla bring a new perspective to the study of gene function and evolution and will be an important tool for furthering our understanding of the role of alleles in conferring disease predisposition. The sequencing and assembly of the human genome have also enabled the detection of interchromosomal block duplications containing novel paralogous genes. Further investigation of the novel genes resulting from ancient duplication of genes with diseaseassociated alleles is required to determine if they are also involved in similar genetic diseases. Moreover, research on those genes may reveal new insights into pathogenesis and therapeutic development. Genomics and bioinformatics will merge with neurobiology to provide powerful new approaches for advancing our understanding of the complex biology and pathology of the human nervous system. 
